Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe coronavirus disease 2019 (COVID-19) outcomes possibly because of dysregulated inflammatory responses. Glucose-regulating medications, such as glucagon-like peptide 1 receptor (GLP-1R) agonists, dipeptidyl peptidase 4 (DPP-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyland, Jennifer E., Raja-Khan, Nazia T., Bettermann, Kerstin, Haouzi, Philippe A., Leslie, Douglas L., Kraschnewski, Jennifer L., Parent, Leslie J., Grigson, Patricia Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660979/
https://www.ncbi.nlm.nih.gov/pubmed/34580086
http://dx.doi.org/10.2337/db21-0385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660979/
https://www.ncbi.nlm.nih.gov/pubmed/34580086
http://dx.doi.org/10.2337/db21-0385

Ejemplares similares